flˈuːdɐɹˌæbaɪnbˈeɪst hˌɛmɐtˌɑːpɔɪˈɛɾɪk stˈɛm sˈɛl tɹænsplɐntˈeɪʃən ˌeɪtʃˌɛssˌiːtˈiː hɐz ʃˈoʊn təbi ɐ fˈiːzᵻbəl tɹˈiːtmənt fɔːɹ ˌaɪsˌiːˈɛl.
Fludarabine-based hematopoietic stem cell transplantation (HSCT) has shown to be a feasible treatment for ICL.